Summary
iShares Health Innovation Active ETF is an ETF - a fund traded on an exchange like a stock - run by IShares. Positions inside: 63. The ten largest make up 46% of the fund.
- Yearly costs
- 0.77%
- Fund size
- $13.8M
- Positions
- 63
- Dividend yield
- 0.23%
- Running since
- 2020
What speaks for it
Nothing stands out in its favour.
What to watch
- 81% of the fund is in one country (United States).
- Costs of 0.77% a year are above the middle of comparable funds (0.44%).
- In the last five years its price once dropped by 36% from its high.
- A small fund with $13.8M under management; small funds get closed more often.
- It trades little: only about $72.4K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +2.1%
- 3 months
- +15%
- This year
- +14%
- 1 year
- +22%
- 3 years
- +60%
- 5 years
- +18%
- Avg. market cap
- $133.1B
- P/E
- 36.7x
- Forward P/E
- 22.1x
- P/S
- 4.5x
- P/B
- 5.5x
- P/FCF
- 23.2x
- EV/EBITDA
- 24.3x
- Dividend yield
- 0.76%
- ROIC
- 3.8%
- ROE
- 11.5%
- Gross margin
- 61.0%
- Operating margin
- -300.6%
- Net margin
- -72.1%
- Payout ratio
- 27.9%
- Net debt/EBITDA
- 4.8x
- Beta
- 0.74
Weighted average of the 50 largest companies, which make up 94% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Moderately concentrated- 1 BLK CSH FND TREASURY SL AGENCY 6.1%
- 2 MRModerna MRNA 5.9%
- 3 GIGilead Sciences GILD 5.6%
- 4 DHDanaher DHR 5.3%
- 5 ABAbbVie ABBV 4.9%
- 6 TMThermo Fisher Scientific TMO 4.5%
- 7 IQIQVIA IQV 3.7%
- 8 BIBiogen BIIB 3.6%
- 9 MTMettler-Toledo MTD 3.6%
- 10 VRVertex Pharmaceuticals VRTX 3.2%
Positions in the fund: 63. The ten largest make up 46% of it.
Composition as of Oct 18, 2026.
Where is it spread?
One countryBy country
- United States 81%
- Switzerland 5.8%
- Denmark 2.0%
- Netherlands 1.6%
- Other countries 9.3%
By company size
- Mega cap 22%
- Large cap 71%
- Mid cap 6.4%
- Small cap 0.2%
- Micro cap 0.1%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 94% of the fund.
Largest country: United States (81%). Largest size group: Large cap (71%).
What does it cost me?
Expensive- A year from $10,000
- $77.00
- Over 20 years
- $3,632
From every $10,000 invested the fund takes $77.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $3,632.
How has it done?
Growing slowly- A year on average, 5 years
- +3.3%
- Deepest drop
- -36%
- Yearly volatility
- 18%
Average yearly growth over the last five years: 3.3%. Deepest drop in these years: 36% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.23%
- Last payment
- $0.08
Over the last 12 months it paid $0.08 per share, which is 0.23% of today's price. The last payment was $0.08 on Jun 15, 2026.
Is it easy to buy and sell?
It trades little- Traded a day
- $72.4K
- Shares a day
- 2.1K
On an average day about $72.4K of the fund changes hands.
How expensive are the companies inside?
Rather expensive- P/E of the companies inside
- 36.7
- Average Bulios Score
- 51 out of 100
Weight by Bulios Fair Price
- Undervalued 16%
- Fairly valued 17%
- Overvalued 67%
On average the companies inside trade for 36.7 times their yearly profit. By Fair Price, 67% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 94% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
2B 2B78.DE iShares Healthcare Innovation UCITS ETF | Ireland | 0.40% | $1.23B | +31% | Reinvests | 41% |
RS RSPH Invesco S&P 500 Equal Weight Health Care ETF | United States | 0.40% | $786.1M | +27% | Pays out | 36% |
DR DRUG.AX BetaShares - Global Healthcare Currency Hedged ETF | Australia | 0.57% | $126.5M | +13% | Pays out | 36% |
XH XHC.TO iShares Global Healthcare Index ETF (CAD-Hedged) | Canada | 0.66% | $408.2M | +14% | Pays out | 36% |
IX IXJ.AX iShares Global Healthcare ETF | Australia | 0.41% | $1.11B | +8.3% | Pays out | 36% |
IX IXJ iShares Global Healthcare ETF | United States | 0.38% | $4.52B | +15% | Pays out | 36% |
